|
"liu tw"的相关文件
显示项目 51-75 / 139 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2017-07 |
Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States-A smoothed Lexis diagram approach
|
Chien, LH;Tseng, TJ;Chen, CH;Jiang, HF;Tsai, FY;Liu, TW;Hsiung, CA;Chang, IS |
| 國家衛生研究院 |
2017-05 |
Prevalence and estimated trend in chemotherapy use near death from population-based studies on cancer patients: A systematic review and meta-analysis
|
Chou, PC;Chen, CH;Liu, TW;Tang, ST |
| 國家衛生研究院 |
2017-04 |
The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation
|
Kuan, FC;Lai, CH;Ku, HY;Wu, CF;Hsieh, MC;Liu, TW;Yeh, CY;Lee, KD |
| 國家衛生研究院 |
2017-04 |
Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas
|
Liao, CT;Wen, YW;Yang, LY;Lee, SR;Ng, SH;Liu, TW;Tsai, ST;Tsai, MH;Lin, JC;Chen, PR;Lou, PJ;Wang, CP;Chu, PY;Hwang, TZ;Leu, YS;Tsai, KY;Terng, SD;Chen, TM;Wang, CH;Chien, CY;Chen, WC;Lee, LY;Lin, CY;Wang, HM;Hsieh, CH;Tsao, CK;Fang, TJ;Huang, SF;Kang, CJ;Chang, KP;Yen, TC |
| 國家衛生研究院 |
2017-04 |
Escalating health care expenditures in cancer decedents' last year of life: A decade of evidence from a retrospective population-based cohort study in Taiwan
|
Hung, YN;Liu, TW;Wen, FH;Chou, WC;Tang, ST |
| 國家衛生研究院 |
2017-03 |
Clinical outcomes of Taiwanese patients with cT4 oral cavity squamous cell carcinoma: Toward the identification of the optimal initial treatment approach for cT4b patients
|
Liao, CT;Wen, YW;Lee, SR;Liu, TW;Tsai, ST;Tsai, MH;Lin, JC;Lou, PJ;Chu, PY;Leu, YS;Tsai, KY;Terng, SD;Chen, TM;Wang, CH;Chien, CY;Chen, WC;Lee, LY;Lin, CY;Wang, HM;Ng, SH;Lin, CH;Fang, TJ;Huang, SF;Kang, CJ;Chang, KP;Yang, LY;Yen |
| 國家衛生研究院 |
2017-02 |
Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma
|
Liao, CT;Chen, HN;Wen, YW;Lee, SR;Ng, SH;Liu, TW;Tsai, ST;Tsai, MH;Lin, JC;Lou, PJ;Wang, CP;Chu, PY;Leu, YS;Tsai, KY;Terng, SD;Chen, TM;Wang, CH;Chien, CY;Chen, WC;Lee, LY;Lin, CY;Wang, HM;Lin, CH;Fang, TJ;Huang, SF;Kang, CJ;Chang, KP;Yang, LY;Yen, TC |
| 國家衛生研究院 |
2017 |
Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C;Group, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2016-12 |
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer
|
Wang, HY;Chang, YL;Cheng, CC;Chao, MW;Lin, SI;Pan, SL;Hsu, CC;Liu, TW;Cheng, HC;Tseng, CP;Liu, SJ;Tsai, HJ;Chang, HY;Hsu, JT |
| 國家衛生研究院 |
2016-10-01 |
The prognostic impact of overall treatment time on disease outcomes of uterine cervical cancer patients: A nationwide cohort study of Taiwan
|
Lin, SM;Hong, JH;Ku, HY;Liu, TW;Chang, TC |
| 國家衛生研究院 |
2016-10-01 |
The influence of hospital volume on disease outcomes of advanced uterine cervical cancer patients: A nationwide cohort study of Taiwan
|
Hong, JH;Lin, SM;Ku, HY;Liu, TW;Chang, TC |
| 國家衛生研究院 |
2016-10 |
The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study
|
Kao, HF;Hsiao, CF;Lai, SC;Wang, CW;Ko, JY;Lo, PJ;Lee, TJ;Liu, TW;Hong, RL |
| 國家衛生研究院 |
2016-09 |
Trend in and correlates of undergoing radiotherapy in Taiwanese cancer patients' last month of life
|
Hung, YN;Cheng, SH;Liu, TW;Chang, WC;Chen, JS;Tang, ST |
| 國家衛生研究院 |
2016-08 |
Characteristics and correlates of increasing use of surgery in Taiwanese cancer patients' last month of life, 2001-2010
|
Liu, TW;Hung, YN;Earle, CC;Liu, TP;Liu, LN;Tang, ST |
| 國家衛生研究院 |
2016-07 |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu, CH;Tseng, CH;Chiang, CJ;Hsu, KH;Tseng, JS;Chen, KC;Wang, CL;Chen, CY;Yen, S;Chiu, CH;Huang, MS;Yu, CJ;Tsai, YH;Chen, JS;Tsai, CM;Chou, TY;Lin, KC;Tsai, MH;Lee, WC;Ku, HY;Liu, TW;Yang, TY;Chang, GC |
| 國家衛生研究院 |
2016-04 |
Receipt of life-sustaining treatments for Taiwanese pediatric patients who died of cancer in 2001 to 2010: A retrospective cohort study
|
Hung, YN;Liu, TW;Lin, DT;Chen, YC;Chen, JS;Tang, ST |
| 國家衛生研究院 |
2016-01 |
S-1 with leucovorin for gastric cancer: How far can it go?
|
Liu, TW;Chen, LT |
| 國家衛生研究院 |
2016-01 |
A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial
|
Chen, MH;Lin, J;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-12 |
Breast cancer quality of care in Taiwan in relation to hospital volume: A population-based cohort study
|
Ou-Yang, F;Hsu, NC;Juan, CH;Huang, HI;Moi, SH;Chen, FM;Liu, TW;Hou, MF |
| 國家衛生研究院 |
2015-12 |
A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer
|
Tang, ST;Liu, TW;Wen, FH;Hsu, C;Chang, YH;Chang, CS;Sung, YC;Hsieh, CI;Chang, SY;Liu, LN;Chiang, MC |
| 國家衛生研究院 |
2015-12 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-11 |
Determinants of hospital death for Taiwanese pediatric cancer decedents, 2001–2010
|
Hung, YN;Liu, TW;Tang, ST |
| 國家衛生研究院 |
2015-08 |
Increasing receipt of high-tech/high-cost imaging and its determinants in the last month of Taiwanese patients with metastatic cancer, 2001-2010: A retrospective cohort study
|
Liu, TW;Hung, YN;Soong, TC;Tang, ST |
| 國家衛生研究院 |
2015-05 |
Preferences for aggressive end-of-life care and their determinants among Taiwanese terminally Ill cancer patients
|
Liu, LN;Chen, CH;Liu, TW;Lin, YC;Lee, SC;Tang, ST |
| 國家衛生研究院 |
2015-05 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
显示项目 51-75 / 139 (共6页)
<< < 1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
|
